Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

A Study on Repairing Mandibular Defect by Means of Tissue-Engineering and Human Bone Morphogenetic Protein-2 Gene Transfection in Osteoporotic Rats

Evaluation of Bone Regeneration by Β Tricalcium Phosphate/Collagen Scaffold Loaded with Bone Morphogenetic Proteins 2 Plasmid in Rat Cranial Defect

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats.

Combination of Î²-TCP and BMP-2 gene-modified bMSCs to heal critical size mandibular defects in rats: Mandibular repair by TCP & BMP2 gene-modified bMSCs

[A Study on the Repair of Bone Defects with Deproteinized Bone Surrounded by Titanium Mesh and Osteoblasts].

[Human Osteoprotegerin Inhibits Osteoclasts and Promotes Hydroxyapatite to Repair the Mandibular Defects in Ovariectomized Rats].

Mandibular Repair in Rats with Premineralized Silk Scaffolds and BMP-2-modified Bmscs

Treatment of bone defect with osteoblasts transfected by transforming growth factor-beta 1 gene in combination with biomimetic biodegradable polymer scaffolds

Bone Regeneration by Rhbmp-2/Collagen in Rat Mandibular Defects

Repair of Rat Cranial Bone Defect by Using Bone Morphogenetic Protein-2-related Peptide Combined with Microspheres Composed of Polylactic Acid/polyglycolic Acid Copolymer and Chitosan

Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats

Repair of Bone Injury and Osteonecrosis with BMP2 Gene Therapy and Stem Cell Transplantation

Engineered Autologous Mesenchymal Stem Cells Repair Femoral Segmental Defects in Old Rats

hBMP-7 Gene Modified Bone Marrow Stromal Cells on the Effects of Healing of Periodontal Furcation Defects in Osteoporosis Rats

Bone tissue engineering application on fracture healing with bone defect as assessed through osteocalcin and bone morphogenetic protein-2 (BMP-2) biomarker examination: experimental study on murine models

Experimental studies regarding injectable chitosan/β-TCP/rhBMP-2 composite in repairing rabbit mandible defects

Experimental Study of Construction of Tissue Engineered Bone by Porous CPC with Bone Mesenchymal Stem Cells Transfected with VEGF Gene for Repair of Rat Skull Defect

The Study of Bone Repair Effect of Recombinant Human Bone Morphogenetic Protein-2 Combined with Artificial Bone Substitute Materials in Alveolar Defect Around the Dental Implant

The use of tissue-engineered bone with human bone morphogenetic protein-4-modified bone-marrow stromal cells in repairing mandibular defects in rabbits.

Bone regeneration by BMP-2 enhanced adipose stem cells loading on alginate gel